Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Other Non-Current Assets: 2022-2024

Historic Other Non-Current Assets for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $283,000.

  • Gossamer Bio's Other Non-Current Assets rose 43.82% to $407,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $407,000, marking a year-over-year increase of 43.82%. This contributed to the annual value of $283,000 for FY2024, which is 54.21% down from last year.
  • As of FY2024, Gossamer Bio's Other Non-Current Assets stood at $283,000, which was down 54.21% from $618,000 recorded in FY2023.
  • Over the past 5 years, Gossamer Bio's Other Non-Current Assets peaked at $680,000 during FY2022, and registered a low of $283,000 during FY2024.
  • Over the past 3 years, Gossamer Bio's median Other Non-Current Assets value was $618,000 (recorded in 2023), while the average stood at $527,000.
  • Data for Gossamer Bio's Other Non-Current Assets shows a maximum YoY tumbled of 54.21% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Gossamer Bio's Other Non-Current Assets stood at $680,000 in 2022, then decreased by 9.12% to $618,000 in 2023, then crashed by 54.21% to $283,000 in 2024.